GSK

70 Actions to Take on Monday’s Rally

During these busy times it pays to stay on top of the latest profit opportunities. Today's blog post features my latest Portfolio Grader rankings More 

9 Low-Risk, High-Yield Dividend Stocks to Buy

Investors need to think about defensive plays with the ability to hang touch in any market, such as these low-risk dividend stocks yielding between 3% and 8%. More 

Prepare for Earnings Season with These 49 Trades

It pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start with these 49 trades to consider More 

These 61 Big Blue Chips Are On the Move

During these times it pays to stay on top of the latest profit opportunities. Today's blog post is be a great place to start. Here are our updated rankings More 

Big Trouble for U.S. Stocks in China

Doing business in China can be hazardous to the health of U.S. stocks. Here's a look at just a few of the challenges and risks. More 

The 10 Best Healthcare Stocks to Buy Now

This list of the 10 best healthcare stocks to buy now includes extremely well-capitalized companies paying extraordinary dividends ... and trading for cheap. More 

GSK, BMY: GlaxoSmithKline to Buy Bristol-Myers HIV Drug

GlaxoSmithKline (NYSE:GSK) is buying HIV drugs produced by Bristol-Myers (NYSE:BMY). The Bristol-Myers medication will cost GlaxoSmithKline up to $1.5 billion, making it an even stronger U.K. pharmaceutical giant. The company will shell out $317 million upfront for the drugs, which treat late-stage HIV. An additional $518 million will be paid depending on particular development and... More